Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

EPHA2

RBC: EPHA2 · Substrate: pEY · high confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Bosutinib99.70.55
Repotrectinib99.60.61
Dasatinib99.40.70
Ponatinib98.60.53
Nilotinib97.60.77
Crizotinib96.00.58
Ripretinib95.20.67
Tivozanib92.60.67
Fostamatinib87.90.61
Cabozantinib87.00.75
Vandetanib86.90.72
Erdafitinib76.40.74
Canertinib72.60.67
Gilteritinib70.40.51
Apatinib60.40.70

Known variants

No variants catalogued.
Open in new tab